Articles
USA Rare Earth Stock Surges Amid Government Investment, Echoing MP Materials' Gains
Federal Stake in Critical Minerals Firms Spurs Investor Optimism for Domestic Supply Chain Resilience
USA Rare Earth Inc. (NASDAQ: USAR) is experiencing significant stock price gains following a strategic investment by the U.S. Commerce Department as p...
FDA Grants Breakthrough Status to Cogent's Bezuclastinib Combination for Advanced Gastrointestinal Stromal Tumors
New clinical trial results reveal a significant reduction in progression risk for GIST patients previously treated with imatinib
Cogent Biosciences has received Breakthrough Therapy Designation from the FDA for its investigational drug bezuclastinib used alongside sunitinib in t...
Steel Dynamics Hits New 52-Week Peak Following Strong Steel Shipment Performance
Despite some operational headwinds, Steel Dynamics delivers solid full-year results with record steel shipments, while continuing to progress on aluminum initiatives
Steel Dynamics reported its fourth-quarter and full-year 2025 financial results, posting record annual steel shipments of 13.7 million tons. The compa...
U.S. Bolsters Domestic Rare Earth Mining Amid Supply Chain Concerns
Federal Investments Aim to Reduce Reliance on Foreign Critical Mineral Imports
The United States government has increased its investment in domestic rare earth mining operations in an effort to decrease dependence on imports, par...
Strategy Inc. Expands Bitcoin Holdings Amidst MSTR Stock Approaching Key Support Level
Company invests $264 million in nearly 3,000 Bitcoin while MSTR shares hover near $160 support mark
Strategy Inc. has acquired 2,932 Bitcoin at an average price above its existing cost basis, funded by significant equity offerings. Despite the expans...
UnitedHealth Group Approaches Q4 Earnings Release Amid Analyst Forecast Adjustments
Leading Analysts Update Price Targets as Market Anticipates Earnings Amid Rising Healthcare Costs
UnitedHealth Group Incorporated is set to report its fourth-quarter earnings on January 27, 2026, with analysts projecting a notable decline in earnin...
Dow Advances Over 100 Points Amid Mixed Corporate Earnings and Market Reactions
Steel Dynamics Reports Weaker-than-Expected Results; Battalion Oil and Brand Engagement Network See Sharp Gains
U.S. equity markets opened higher with the Dow Jones Industrial Average increasing by over 100 points, reflecting a modest positive investor sentiment...
Private Business Jet Crash in Maine Kills Seven Amid Severe Snowstorm
One Crew Member Survives with Serious Injuries as Investigations Commence
A private Bombardier Challenger 600 business jet crashed during takeoff at Bangor International Airport amidst a significant winter storm, resulting i...
Mastering Tortiglioni: An Essential Guide to Traditional Italian Pasta Preparation
Unlocking the nuances of cooking tortiglioni combined with roasted peppers and eggplant in a classic Italian dish
This article provides a detailed and methodical approach to preparing tortiglioni pasta paired with a vibrant sauce of roasted peppers, eggplant, and ...
CoreWeave Strengthens Nvidia Partnership with $2 Billion Investment to Expand AI Infrastructure
Nvidia's substantial capital infusion aims to accelerate CoreWeave's AI factory development by 2030, reinforcing strategic cloud platform collaboration
CoreWeave, Inc. has announced a significant enlargement of its partnership with Nvidia Corporation, marked by a $2 billion investment from Nvidia to s...
Ease Your Tax Season Worries: Practical Guidance for Filing Your 2025 Return
Early action, organization, and expert assistance can simplify the upcoming tax filing process
As the IRS begins accepting tax returns for the 2025 fiscal year from January 1, taxpayers have until April 15 to submit their forms. Despite the comm...
Sarepta Therapeutics Shares Rise Following Promising Three-Year Data for Elevidys in Duchenne Muscular Dystrophy
Phase 3 EMBARK Study Reveals Sustained Motor Function Benefits and Safety Profile in Ambulatory Patients
Sarepta Therapeutics reported positive three-year functional outcomes from the EMBARK Phase 3 trial evaluating Elevidys (delandistrogene moxeparvovec-...